BioSpace News Archive

Orgenesis Inc. announced that Vered Caplan, CEO of Orgenesis, appeared as a guest during the “Israel Business Weekly” segment hosted by Michelle Makori and Eric Landskroner on the i24News Network.

Cross-industry collaboration will accelerate digital solutions and support R&D innovation by customers

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel drug candidates in indications of high unmet medical need, reported financial results for the third quarter ended September 30, 2019.

RedHill Biopharma Ltd. announced that it will report its third quarter 2019 financial results and operational highlights on Tuesday, November 19, 2019.

Antares Pharma, Inc. announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies 2019 London Healthcare Conference on Wednesday November 20, 2019, at 11:20 am / 6:20 am in London, UK.

Milestone Pharmaceuticals Inc. reported financial results for the third quarter ended September 30, 2019 and provided a clinical and corporate update.

Protagonist Therapeutics, Inc. announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present at two upcoming healthcare investor conferences in New York..

Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announces its financial results for the third quarter, ending September 30, 2019.

X-Biotix Therapeutics, Inc. announced pipeline and corporate progress updates.

Verastem, Inc., announced that Andrei Shustov, M.D., Professor of Medicine and Hematology, University of Washington, Associate Member, Clinical Research Division, Fred Hutchinson Cancer Research Center and President and Founder of the T-Cell Leukemia and Lymphoma Foundation has been selected to receive the Company’s Innovation in Care Award.